Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol and Selenium for Diabetic Foot Ulcer
NCT06117436Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol, selenium in diabetic foot ulcer (DFU), sponsored by Ain Shams University. Started Oct 2023; status: completed.
02
Drugs
cilostazolselenium
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06117436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06117436.